Skip to main content
Medicines, medical devices

Guidance and regulation

Skip to results
447 results sorted by Most viewed
  • You must get permission to export certain drugs and medicines.

  • An overview of the systems and processes DHSC and NHS England use for responding to medicine shortages.

  • There are changes to the legislation on reference medicinal products (RMPs) used to support abridged marketing authorisation applications.

  • Guidance on the process for ending a clinical trial.

  • The Innovative Devices Access Pathway (IDAP) pilot is designed to accelerate the development of innovative medical devices that meet an unmet clinical need in the NHS and support their integration into the UK market.

  • How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.

  • A list of herbal medicines currently holding a traditional herbal registration (THR) granted by the Medicines and Healthcare products Regulatory Agency (MHRA).

  • Details of the organisations that are currently approved to undertake conformity assessments on medical devices.

  • A digital platform designed to facilitate the reporting, monitoring, and management of medical device incidents.

  • The call for applications for phase 3 of the AI Airlock is now open.

  • Information on applying quality by design, risk‑based quality management, and proportionate oversight in UK clinical trials.

  • Keep up to date with the latest information from the UK GLP monitoring authority.

  • How to write clear and effective field safety notices (FSNs) for medical devices.

  • Guidance for UK wholesalers and manufacturers on how to import human medicines including unlicensed medicines, how to apply for a licence and how much it costs.

  • Consumer advice and details of how to report problems with e-cigarettes with guidance on how to place an e-cigarette on the market in Great Britain and Northern Ireland, including the notification scheme.

  • Information about how the MHRA regulates medical devices in Northern Ireland and what legislation applies to manufacturers and suppliers.

  • Guidance on clinical trials that are categorised as ‘notifiable’.

  • Guidance on the safe and effective use of GLP-1 medicines for weight loss and diabetes.

  • The MHRA will review applications for orphan designation at the time of a marketing authorisation (MA) or variation application.

  • The Vaccine Development Evaluation Centre (VDEC) at Porton Down in Wiltshire facilitates the development and evaluation of new vaccines and therapeutics.